Submitted by 21232f297a57a5a... on Tue, 09/24/2013 - 10:34am
Numerous people may say they want to grow up to be a heart surgeon, but very few actually achieve that goal.
Holly Mewhort, MD, PhD, is one of those individuals.
Over two-thirds of people age 65 or older with diabetes die from some form of heart disease. People with diabetes are >3 times more likely to develop cardiovascular diseases. That means for large portions of the population, to prevent or slow the development of heart disease, we need to look at diabetes.
From July 29th through to August 1st, 2016 the Libin Cardiovascular Institute of Alberta hosted more than 80 participants from Canada and China at the University of Calgary for the Biennial Canada-China Symposium of Atherosclerosis, Thrombosis and Vascular Biology.
Calgary to host this year's Cardiac Arrhythmia Network of Canada's public forum on Wednesday, Sept. 14, 2016. Libin Institute will join, along with national experts, to share knowledge, advice, and research at this year's event.
After tremendous success with its inaugural Libin 101 event on Feb. 25, 2016, the Libin Institute is proud to announce Libin 101 will now be an ongoing free public educational event series.
Member Kathryn King-Shier (right) was honoured with a prestigious Canadian Nurses Association (CNA) award at this year’s biennial conference, held in late June in Saint John, N.B.
Dr. Brenda Hemmelgarn mixes research and mentoring in search for solutions and earns herself the University of Calgary’s 2016 Killam Annual Professorship.
On Saturday May 9, the Health Sciences Centre was buzzing with community based events and the Libin Cardiovascular Institute was part of two of them: TEDxCalgary and a Jane's Walk.
Libin researcher Kara Nerenberg part of study hoping to predict which first-time moms are at risk of developing preeclampsia early in their pregnancies.
Recap and photos from the 2016 Libin Institute's Tine Haworth Cardiovascular Research Day.
Libin members part of new study that is looking to recruit study participants to determine if interventions with their pharmacist and physician will help offset cardiovascular challenges.